Revelation Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -5 | -6 | |
EBITDA | -3,315 | -3,085 | -2,565 | -1,936 |
EBIT | -3,323 | -3,092 | -2,571 | -1,943 |
Net Income | -3,323 | -3,009 | -2,511 | -1,907 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,596 | -3,286 | -1,966 | -1,588 |
Cash | 11,482 | 14,113 | 10,700 | 12,708 |
Basic Shares | 3,829 | 3,207 | 620 | 2,644 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -27 | -27 | -25 | -40 |
EBITDA | -9,043 | -7,947 | -8,631 | -10,839 |
EBIT | -9,070 | -7,975 | -8,656 | -10,864 |
Net Income | -8,913 | -15,038 | -120 | -10,829 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,269 | -18,340 | -7,286 | -11,219 |
Cash | 10,700 | 6,499 | 11,991 | 5,252 |
Basic Shares | 620 | 171 | 14 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.87 |
2026-03-31 | -$2.71 |
2025-12-31 | -$1.65 |
2025-09-30 | -$7.08 |